Flubichin methanesulfonate

Drug Profile

Flubichin methanesulfonate

Alternative Names: VUFB 12950

Latest Information Update: 14 Apr 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator VUFB
  • Developer Zentiva
  • Class Analgesics; Anti-inflammatories; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 13 Feb 2001 Suspended-Preclinical for Pain in Czech Republic (Unknown route)
  • 16 Oct 1995 A study has been added to the pharmacokinetics and pharmacodynamics sections
  • 21 Aug 1995 No-Development-Reported for Pain in Czech Republic (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top